Related Experiment Video
Updated: Jun 11, 2025

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
Published on: July 28, 2023
Challenge Dose Titration in a Mycobacterium bovis Infection Model in Goats
Elisabeth M Liebler-Tenorio1, Nadine Wedlich1, Julia Figl1
1Institute of Molecular Pathogenesis, Friedrich-Loeffler-Institut, 07743 Jena, Germany.
Goats infected with Mycobacterium bovis showed no clinical signs but developed immune responses and lung lesions. These established goat models with dose-dependent outcomes can aid in testing new tuberculosis vaccines.
Area of Science:
- Veterinary Medicine
- Infectious Diseases
- Immunology
Background:
- Goats are natural reservoirs for Mycobacterium bovis (M. bovis), causing economic losses.
- Goat models of M. bovis infection mimic human tuberculosis, offering research potential.
Purpose of the Study:
- To characterize Mycobacterium bovis challenge models in goats.
- To establish reproducible models for vaccine development.
Main Methods:
- Goats were endobronchially inoculated with varying doses of M. bovis.
- Clinical signs, pathogen shedding, and immune responses were monitored.
- Lesions were assessed via CT, histology, and bacteriology post-necropsy.
Main Results:
- Infected goats remained asymptomatic but showed positive immune responses (IGRA, antibodies, SICCT) and T-cell activation.
- M. bovis was cultured from feces, not nasal swabs.
- Paucibacillary granulomas formed in lungs and lymph nodes; high doses led to larger lesions and early generalization.
Conclusions:
- Reproducible M. bovis challenge models in goats were established.
- Dose-dependent lesion development was observed.
- These models are suitable for evaluating veterinary and human tuberculosis vaccines.
More Related Videos
15:57Application of Long-term cultured Interferon-γ Enzyme-linked Immunospot Assay for Assessing Effector and Memory T Cell Responses in Cattle
Published on: July 11, 2015
10:29A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
Published on: March 24, 2017